Monte Rosa Therapeutics Inc.
GLUE | NASDAQ
$12.26
+$0.13 (+1.07%)
At close: Sep 21, 2026, 4:00 PM ET
$12.43
+$0.17 (+1.39%)
Pre-market:
Sep 22, 2026, 8:52 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -87.9M | -44.5M | -46.14M | -27.08M | -12.3M | 46.89M | 13.44M | -23.86M | -30.31M | -31.97M | -33.25M | -34.88M | -35.18M | -32.04M | -30.78M | -27.32M | -26.47M | -23.93M | -23.44M | -19.84M | -18.41M | -12.28M |
Depreciation & Amortization | 3.94M | 2.03M | 2.09M | 2.1M | 2.13M | 2.05M | 2.06M | 2.1M | 2.06M | 1.9M | 1.85M | 1.83M | 1.39M | 1.15M | 1.07M | 1.03M | 889K | 753K | 809K | 582K | 467K | 274K |
Stock-Based Compensation | 11.92M | 5.95M | 4.31M | 4.36M | 4.89M | 5.3M | 4.47M | 4.28M | 4.5M | 4.87M | 4.07M | 4.47M | 4.15M | 3.97M | 3.33M | 3.21M | 2.87M | 2.25M | 1.86M | 2.07M | 1.02M | 252K |
Other Working Capital | -7.59M | -11.23M | 9.46M | 115.23M | -26.64M | -86.53M | 95.92M | -9.3M | 6.01M | -7.82M | 51.94M | 3.31M | 6.95M | 2.28M | 1.92M | -205K | 1.58M | -4.5M | 1.86M | 3.63M | 3.63M | -2.12M |
Other Non-Cash Items | -1.86M | -985K | 87K | -466K | -737K | -1.09M | -696K | -1.09M | -1.09M | -69K | 1.26M | -497K | -1.44M | -1.14M | 352K | 1.21M | 994K | 209K | 4K | 13K | n/a | 960K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -7.59M | 141K | -3.36M | 121.52M | -28.71M | -98.64M | 109.65M | -2.43M | -2.93M | -12.9M | 57.7M | 4.37M | 5.75M | 4.64M | 2.07M | 1.27M | 1.21M | -6.69M | 6.6M | -625K | 3.34M | -3.03M |
Operating Cash Flow | -81.48M | -37.37M | -43.01M | 100.43M | -34.72M | -45.49M | 128.92M | -20.99M | -27.77M | -38.17M | 29.63M | -24.71M | -25.32M | -23.41M | -23.96M | -20.6M | -20.5M | -27.4M | -14.17M | -17.79M | -13.58M | -13.82M |
Capital Expenditures | -6.59M | -1.87M | -767K | -651K | -1.7M | -1.59M | -183K | -399K | -2.02M | -1.38M | -1.69M | -1.66M | -6.45M | -9.18M | -7.27M | -1.42M | -2.55M | -1.56M | -3.13M | -1.76M | -2.7M | -2.22M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.99K | n/a | 62K | n/a | 46.67K | -16K | n/a | 125K | 12K | n/a | n/a | n/a |
Purchase of Investments | -408.07M | -332M | -153.66M | -65.97M | -19.03M | -138.01M | -67.96M | -32.37M | -73.96M | -56.07M | -27.51M | -7.81M | n/a | -67.82M | -94.37M | -59.4M | -51.7M | -178.96M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 124.81M | 72.87M | 89.36M | 104.76M | 46.05M | 39.37M | 37.25M | 70.52M | 14.82M | 67.31M | 43.5M | 45.1M | 25M | 97.33M | 47.7M | 90.3M | 40M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.99K | n/a | n/a | n/a | -46.67K | n/a | n/a | n/a | n/a | 67K | n/a | n/a |
Investing Cash Flow | -289.86M | -261M | -65.07M | 38.14M | 25.32M | -100.23M | -30.9M | 37.75M | -61.16M | 9.85M | 14.3M | 35.63M | 18.55M | 20.33M | -53.94M | 29.49M | -14.25M | -180.52M | -3.05M | -1.69M | -2.7M | -2.22M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -387K | n/a | n/a | n/a | n/a | n/a | 47.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 379K | n/a | n/a | n/a | n/a | -1.56M | 205.47M | n/a |
Financial Cash Flow | 331.55M | 328.34M | 29.62M | 348K | 365K | 14K | 608K | 15K | 98.02M | 246K | 25.17M | 1.1M | 1.2M | 18K | 20.43M | -217K | 96K | 153K | -135K | 29.46M | 205.47M | 142.77M |
Net Cash Flow | -39.79M | 29.98M | -78.46M | 138.91M | -9.03M | -145.72M | 98.63M | 16.77M | 9.1M | -28.35M | 69.05M | 12.03M | -5.78M | -3.07M | -57.47M | 9.69M | -34.64M | -207.77M | -20.96M | 9.97M | 188.62M | 126.74M |
Free Cash Flow | -88.07M | -39.24M | -43.78M | 99.78M | -36.42M | -47.08M | 128.74M | -21.39M | -29.79M | -39.55M | 27.95M | -26.37M | -31.77M | -32.59M | -31.23M | -22.02M | -23.05M | -28.97M | -17.3M | -19.55M | -16.28M | -16.03M |
Adj. Free Cash Flow | -99.99M | -45.19M | -48.09M | 95.41M | -41.31M | -52.38M | 124.27M | -25.68M | -34.29M | -44.42M | 23.87M | -30.83M | -35.93M | -36.56M | -34.56M | -25.23M | -25.93M | -31.22M | -19.15M | -21.62M | -17.3M | -16.28M |
Maintenance CapEx | -3.94M | -1.87M | -767K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.69M | -1.66M | -1.39M | -1.15M | -1.07M | -1.03M | -889K | -753K | -809K | -582K | -467K | -274K |
Growth CapEx | -2.65M | n/a | n/a | -651K | -1.7M | -1.59M | -183K | -399K | -2.02M | -1.38M | n/a | n/a | -5.06M | -8.03M | -6.2M | -383K | -1.66M | -809K | -2.32M | -1.17M | -2.23M | -1.94M |
Owner Earnings | -85.43M | -39.24M | -43.78M | 100.43M | -34.72M | -45.49M | 128.92M | -20.99M | -27.77M | -38.17M | 27.95M | -26.37M | -26.72M | -24.56M | -25.03M | -21.63M | -21.39M | -28.16M | -14.98M | -18.38M | -14.05M | -14.09M |
Add to Watchlist
Select watchlists to add or remove GLUE